CG Oncology, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC CGON

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,090,894

Value ($000)

45,294

Weight

0.0%

2024 Q2 - 2025 Q4 (7 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	45,294	0.0%	1,090,894	12/31/2025
2025 Q3	11/14/2025	31,431	0.0%	780,302	9/30/2025
2025 Q2	8/14/2025	22,272	0.0%	856,597	6/30/2025
2025 Q1	5/19/2025	4,393	0.0%	179,363	3/31/2025
2024 Q4	2/14/2025	3,611	0.0%	125,902	12/31/2024
2024 Q3	11/14/2024	797	0.0%	21,122	9/30/2024
2024 Q2	8/14/2024	746	0.0%	23,625	6/30/2024